Keane Robert S

Director Robert S. Keane sells 237.7K shares at $26.93 avg for $6.4M; post-transaction holdings zero from derivatives conversion.

Director Robert S. Keane executed 2 separate sales totaling 237.7K shares for $6,401,050.00 on May 8–9, 2025, at a blended average price of $26.93. The current stock price is $29.19, representing a +8.4% premium to the sales. Notably, this filing involves a derivative-conversion transaction, meaning the insider's real economic position resides in Table II derivative securities not yet populated in the database; the zero Table I holdings post-transaction does not necessarily indicate a complete exit from economic exposure. His prior sales at ATRO show a -9.1% 30-day return, though longer-term outcomes remain unmeasurable. His cross-ticker track record shows 9 prior sells with a 100.00% well-timed rate at the 90-day mark (avg 90d return -19.4%), suggesting historical skill in sell timing, but timing evaluation for this transaction is premature pending derivative position disclosure.

Director Keane sells entire 77,099-share position at $24.55 for $1.9M; stock up 50.8% in 90 days from unprofitable base.

Director Robert S Keane liquidated his entire holding of 77,099 shares through 2 separate sales totaling $1,892,780.45 at $24.55 per share on 2025-03-07, reducing his position from 77,099 shares to 0 shares post-transaction. The complete exit occurs against a backdrop of significant recent price appreciation: the stock has risen 50.8% over the past 90 days and 28.6% over the past 30 days, now trading at $24.59—only 1.3% below its 52-week high of $24.91. This timing is notable given Astronics' fundamental challenges: the company reported negative net income of $-11.7M in the latest quarter and was unprofitable over its most recent full fiscal year, despite posting 15.4% annual revenue growth to $203.7M and a strained valuation (P/E of 204.92 driven by the loss). Keane's cross-ticker track record shows 7 prior open-market sells with a 100.00% well-timed rate over 90 days, meaning the stock fell after those sales—a pattern that historically has preceded declines, though this particular filing provides no information about whether a scheduled trading plan governed the transaction timing.

CEO Robert S Keane sells 71,019 shares of CMPR for $7.1M across 7 transactions, retains 987.2K shares

Robert S Keane, CEO and Chairman of Cimpress plc, executed 7 separate sales totaling 71,019 shares for $7,051,345.65 at a blended average price of $99.29 on August 29-30, 2024. The sale represents a 6.7% reduction in his pre-transaction holdings of 1,058,200 shares, leaving him with 987,181 shares post-transaction. At the current price of $94.85, the stock has declined 6.1% from its 52-week high of $101.04, where the CEO's transactions occurred near that peak. The company reported a net loss of $-3,978,000 in its latest quarter against revenue of $780,588,000, though annual revenue growth stands at 6.9% year-over-year. The CEO retains substantial holdings post-sale, preserving significant ongoing ownership alignment with shareholders.